Results 21 to 30 of about 1,591,431 (356)
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Journal of Hematology & Oncology, 2022 Research on tumor immunotherapy has made tremendous progress in the past decades, with numerous studies entering the clinical evaluation. The cancer vaccine is considered a promising therapeutic strategy in the immunotherapy of solid tumors.
Jian Liu +5 more
semanticscholar +1 more source
Nature reviews. Immunology, 2021 Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries.
J. Tregoning +4 more
semanticscholar +1 more source
Vaccines, 2021 COVID-19 vaccines have been developed with unprecedented speed which would not have been possible without decades of fundamental research on delivery nanotechnology.
T. H. Thi +5 more
semanticscholar +1 more source
Innate immune mechanisms of mRNA vaccines
Immunity, 2022 The lipid nanoparticle (LNP)-encapsulated, nucleoside-modified mRNA platform has been used to generate safe and effective vaccines in record time against COVID-19.
Rein Verbeke +3 more
semanticscholar +1 more source
Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment [PDF]
, 2014 There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic ...
Achilefu, Samuel +10 more
core +2 more sources
Influenza and memory T cells : how to awake the force [PDF]
, 2016 Annual influenza vaccination is an effective way to prevent human influenza. Current vaccines are mainly focused on eliciting a strain-matched humoral immune response, requiring yearly updates, and do not provide protection for all vaccinated individuals.
Glezen +12 more
core +3 more sources
Acknowledgement to Reviewers of Vaccines in 2014
Vaccines, 2015 The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Vaccines Editorial Office
doaj +1 more source
npj Vaccines, 2023 Seasonal influenza vaccines must be updated annually and suboptimally protect against strains mismatched to the selected vaccine strains. We previously developed a subunit vaccine antigen consisting of a stabilized trimeric influenza A group 1 ...
Maarten Swart +21 more
doaj +1 more source
Human and bovine respiratory syncytial virus vaccine research and development [PDF]
, 2008 Human (HRSV) and bovine (BRSV) respiratory syncytial viruses (RSV) are two closely related viruses, which are the most important causative agents of respiratory tract infections of young children and calves, respectively.
Deplanche, Martine +2 more
core +2 more sources
Acknowledgement to Reviewers of Vaccines in 2016
Vaccines, 2017 The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Vaccines Editorial Office
doaj +1 more source